Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Kidney Neoplasms × Vincristine × Clear all

Phase

Phase 3 3 Phase 2 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma, Large B-Cell, Diffuse 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma 12 Lymphoma, Non-Hodgkin 10 Lymphoma, Mantle-Cell 7 Lymphoma, B-Cell 7 Burkitt Lymphoma 7 Rhabdomyosarcoma 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Follicular 6 Leukemia 5 Immunoblastic Lymphadenopathy 5 Lymphoma, Large-Cell, Anaplastic 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Sarcoma, Ewing 3 Recurrence 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Primary Effusion 3 Sarcoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Osteosarcoma 2 Neuroblastoma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Hodgkin Disease 2 Enteropathy-Associated T-Cell Lymphoma 2 Wilms Tumor 1

Interventions

pembrolizumab 6 aldesleukin 6 Cyclophosphamide 6 fludarabine phosphate 5 fludarabine 4 Nivolumab 4 durvalumab 3 Sorafenib 3 Radiotherapy 3 Filgrastim 3 Everolimus 3 Temozolomide 2 Peripheral Blood Stem Cell Transplantation 2 Isotretinoin 2 Interleukin-2 2 Interferon-alpha 2 Fluorouracil 2 Dexamethasone 2 Cyclosporine 2 Bevacizumab 2 vorolanib 1 tremelimumab 1 tocilizumab 1 talazoparib 1 sargramostim 1 poly ICLC 1 palbociclib 1 oblimersen 1 isoquercitrin 1 guadecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡